SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

ARS Pharmaceuticals, Inc. backtest

10 trend-following strategies were compared on the full daily history of ARS Pharmaceuticals, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 6.7%, MDD -20.8%).

Data 2020-12-04 ~ 2026-07-31daily bars 1,419 (5.7 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -24.5%, drawdown -95.2%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 6.7%, MDD -20.8%, Sharpe 0.55, 4% exposure.

CAGR reference leader: EMA 크로스오버 — CAGR 13.1%, MDD -51.9%, exposure 48%.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 31.1%p higher than buy and hold, while drawdown improves by 74.4%p (CAGR 6.7%, MDD -20.8%, exposure 4%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=28, threshold=29
6.7%-20.8%0.550.321.4x24%
EMA 크로스오버
fast=7, slow=12
13.1%-51.9%0.500.252.0x7848%
Donchian 채널 돌파
entryN=98, exitN=43
12.0%-39.8%0.500.301.9x632%
SMA 크로스오버
fast=24, slow=156
12.0%-56.8%0.490.211.9x1038%
Supertrend
period=24, mult=2
11.8%-61.5%0.470.191.9x4849%
ROC 모멘텀
n=45, threshold=0.02
7.0%-50.3%0.380.141.5x8248%
볼린저 밴드 돌파
n=28, k=2.8
4.6%-41.3%0.310.111.3x1819%
Parabolic SAR
step=0.015, maxStep=0.12
-5.2%-75.3%0.12-0.070.7x9449%
Keltner 채널 돌파
emaPeriod=29, atrPeriod=18, mult=3
-3.0%-47.4%0.01-0.060.8x1616%
MACD
fast=11, slow=50, signal=11
-20.9%-83.0%-0.24-0.250.3x7852%
Buy and hold-24.5%-95.2%0.06-0.260.2x1100%
1x 2021 2022 2023 2024 2025 2026 EMA 크로스오버ADX / DI 방향성Buy and hold
ADX / DI 방향성 (Sharpe leader), EMA 크로스오버 (CAGR reference), Buy and hold.
0% -24% -48% -71% -95% 2021 2022 2023 2024 2025 2026 Buy and holdEMA 크로스오버ADX / DI 방향성
ADX / DI 방향성 maximum drawdown -20.8% (2024-03-28 → 2024-04-25), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next